1

CURRICULUM VITAE Chandra K. Mittal, B.S., M.S., Ph.D., FCP

Professor of Bio-Medical Sciences & Technologies

(Cell Phone: 713-398-6175) Office E-Mail: Chandra.Mittal@hccs.edu Personal E-Mail: drckmittal@yahoo.com

-------------------------------------------------------------------------------------------------------------------------------------------------------------------

EDUCATION:

B.S., Biology/Chem/Geology (1967) First Class, Univ. of Lucknow, India M.S ., Biochemistry (1969) First Class, Univ. of Lucknow, India Ph.D., Biochemical Pharmacol. (1974) All-India Institute of Medical Sciences, New Delhi, Postdoc, Pharmacology (1974-1977) Univ. of Virginia Med. Center, Charlottesville, VA Elected Fellow, FCP (1987) American College of Clinical Pharmacology Certificated in Distance Education Tech. Canvas-Eagle Online/Blackboard - LMS Credentialed to Teach: Medical Biotech, Anatomy & Physiology,

Pharmacology, Pathophysiology, Nutrition

SIGNIFICANT SCIENTIFIC CONTRIBUTIONS:

1998 Nobel Prize in Medicine or Physiology: Co-Discover & Lead author of Nitric Oxide Signaling System with Dr. Ferid Murad who received 1998 Nobel Prize for this discovery.

Nitric Oxide has Diagnostic, Therapeutic and Nutritional implications for Cardio-Vascular health, Sexual health, Erectile Dysfunction, etc.

PROFESSIONAL APPOINTMENTS:

2014-Present Professor of Bio-Medical Sciences & Technologies- HCC

2002-2014 Professor, Associate Chair & Coordinator- Medical Biotechnology – HCC

1996-2002 Scientific Director, Herichson Biotech, Inc. Texas, USA

1992-1995 Research Professor (Pharmacology), TSU College of Pharmacy, Houston, Texas, USA

1992 Supervisor, Division of Clinical Immunodiagnostics, NHL (now LabCorp) Houston

1991-1992 Drug Discovery Consultant, Abbott Laboratories, Inc., North Chicago, IL, USA

1987-1991 Director, Bio-Medical Res & Lab Medicine, Escorts Heart Research Institute, New Delhi,

1980-1987 Assistant Professor of Pharmacology, Univ. IL Coll. Med., Peoria, Illinois, USA

1977-1980 Instructor in Pharmacology, Univ. Virginia Sch. Med. Charlottesville, Virginia, USA

1974-1977 Research Associate in Pharmacology, Univ. Virginia Sch. Med. Charlottesville, Virginia

1969-1974 Research Fellow, All-India Institute of Medical Sciences, New Delhi, INDIA

2

HONORS: Editorial Board, Journal of Molecular Biology & Therapeutics (2018-Present) Editor, Global Vaccine & Vaccination Journal (2016 – Present) Advisory Board – Healthline Magazine, Voice of Asia Group Publication, Houston (2016-Present) Editor, Journal of Microbiology & Experimentation (2014 – Present)

NIH-Member (ad hoc) – NIH, Cardiovascular IRG, Hypertension & Microcirculation Study Section (2004-Present) NSF-Member (ad hoc)–National Science Foundation, Adv Tech Education Review Group NIH- Expert Consultant – National Institutes of Health-RCMI Review Panel ( 1994), Elected Fellow, American College of Clinical Pharmacology, USA (1987) Manuscript Reviewer - BBA, Life Sci., JMCC, etc (1977-1996) Research Grant Reviewer, Am. Heart Assoc. (1981-1986)

AWARDS: ASIOA Special Recognition Award, (1999): - For 1998 Nobel-Prize winning Discovery of Nitric Oxide Signaling Dr. & Mrs. G. P. Talwar Oration Award (2007), Association of Clinical Biochemists of India (ACBI)

NISOD Excellence Award, 2005, National Institute for Staff & Organizational Development (NISOD), USA Research Fellowship, Council of Scientific & Industrial Research, Govt. of India, (1969-1974)

University Merit Scholarship, University of Lucknow, India (1966-1967) Undergraduate Meritorious Scholarship, Govt. of U.P. India (1965-66) High School Merit Scholarship, Govt. of U.P. India (1961-1963)

ADMINISTRATIVE ASSIGNMENTS:

Medical Biotechnology Program Coordinator, HCC (2011-2014)

Associate Chair, Department of Medical Biotechnology, HCC (2003-2011)

Director of Research & Training, Escorts Heart Res. Institute, India (1987-1991) Ex-Officio Member – Medical Biotechnology Advisory Board – HCC (2002 – 2014) Member, Institutional Policy & Procedures Committee-HCC 2013) Member, Institutional Policy & Procedures Committee – HCC (2011) Member, Process Technology Faculty Search Committee – HCC (2012) Member, Petroleum Engineering Technology Faculty Search Committee-HCC 2012) Chair, Instrumentation Technology Faculty Selection Committee, HCC (2005) Member, Committee on International Programs, Houston Community College System (2002-Present) Member, Committee on Ph.D. Curriculum Development, Texas Southern Univ. (1994) Member, Scientific Advisory Board, Escorts Heart Res. Institute, New Delhi, India (1987-1991) Chairman, Executive Committee, Dept. Biomed. Sci, Univ ILL. Coll. Med. (1980-1985) Chairman, Committee of Research, University of Illinois. Coll. Med. (1980-87) Member, Committee on Pharmacology Curriculum, Univ ILL. Coll. Med. (1983-1985) Member, Committee on Student Appraisal, Univ ILL. Coll. Med. (1985 – 1987) Member, Committee on Grad. Med. Edu., Univ IL. Coll. Med. (1981- 1982)

ADVISOR / CONSULTANT:

Ortho Pharmaceuticals, Inc. Raritan, New Jersey (1984)

Abbott Laboratories, Inc. Abbott Park, Illinois (1989-1992)

LifeCell Corporation, The Woodlands, Texas (1990)

Aronex Pharmaceuticals, Inc., The Woodlands, Texas (1999) Neogenis Labs, Inc. Austin, Texas, USA (2013)

3

COMMUNITY SERVICES

Co-Founder, Indo-American Association, (IAA) Houston, TX, USA (1993) President, Indian Association of Peoria, Peoria, Illinois, USA (1983) Founding Member, Society of Young Scientists, AIIMS, New Delhi, India (1973) Co-Founder & President, Naveen Tarun Sangh, Lucknow, India (1968-69)

MEDIA FEATURES

1. Indian J. Pharmacology 30: 347-350 (1998) 2. Lancet, October, 1998 3. Express Pharma Pulse, December 10, 1998 5. Times of India, October 28, 1998 8. Deccan Herald, October 22, 1998 9. The Telegraph, October 25, 1998 10. The Economics Times, January 10, 1999 11. Times of India, January 24, 1999 12. Hindustan (Hindi), March, 2000 13. Biospectrum, May 2005 14. Biospectrum, September 2006

MEDIA INTERVIEWS

1. IGNOU-TV, Nobel Prize winning Discovery of Nitric Oxide, 1999 2. Invention Intelligence, March-April, 1999 3. Biospectrum, May, 2005 (pp, 18-19): Academic and workforce track are two models of biotech education in US. 4. Biospectrum India, September, 2006 (pp, 22-24): The potential for biotechnology business in India.

PROFESSIONAL EXPERIENCE

Teaching Experience in Health Sciences:

H o u s t o n C o m m u n i t y C o l l e g e H u m a n A n a t & P h y s i o l , N u t r i t i o n 2 0 1 4 - P r e s e n t

H o u s t o n C o m m u n i t y C o l l e g e M e d . B i o t e c h n o l o g y 2 0 0 2 - 2 0 1 4

T e x a s S o u t h e r n U n i v . C o l l . P h a r m M e d . P h a r m a c o l o g y 1 9 9 2 - 1 9 9 5

U n i v e r s i t y o f I l l i n o i s C o l l . M e d . M e d . P h a r m a c o l o g y 1 9 8 0 - 1 9 8 7

U n i v e r s i t y o f V i r g i n i a S c h . M e d . M e d . P h a r m a c o l o g y 1 9 7 7 - 1 9 8 0

A l l - I n d i a I n s t . M e d . S c i – N e w D e l h i M e d . B i o c h e m i s t r y 1 9 6 9 - 1 9 7 4

Scholarly Leadership: I have had a successful career in academia as demonstrated by research publications in the peer-

reviewed national and international journals; supervision of research students, post-docs, technicians, fellows. I have won

many meritorious scholarships, and received national and international honors and recognitions for my leadership in

research and management capabilities, including the 2005 Excellence Awards from the National Institute for Staff &

Organizational Development (NISOD). My original research work with discovery of Nitric Oxide-Cyclic GMP Signaling

conducted at the University of Virginia was recognized by the 1998 Nobel Prize in Medicine or Physiology.

4

Higher Education Administration: Participated in administrative functions at universities, medical institutions, and

Government Panels. Served as Chairman and Member of various institutional committees as listed above. As Associate

Chair of Biotech program, developed Program Student Learning Outcomes (PSLOs) and Student Learning Outcomes

(SLOs) and set criteria for program evaluations. Created new courses for HCC’s biotechnology program.These included

Principles of Biochemistry (BITC-1403), Medical Biotechnology (BITC-2445), Immunological Techniques (BITC-2472) for

AAS degree. These courses have been now adopted by the Texas Higher Education Coordinating Board in its Workforce

Education Curriculum Manual (WECM). As Coordinator of HCC’s Biotechnology Program, carried out 5-yearly Program

Review of Biotechnology Program in 2012, and made recommendation to strengthen Biotech program at HCC.

Developed new curricula and course descriptions for Advanced Technical Certificates (ATCs) in Clinical Research

Technology involving drug trials, Biomedical Research Technology and Clinical Molecular Diagnostics for HCC Coleman

College of Health Sciences. These skills are in high demand at the Texas Medical Center (TMC) institutions and other

healthcare industry with large employment opportunities.

Clinical Diagnostics Services: For 1987 to 1992, served as Director of Lab Medicine at the Escorts Heart Research

Institute, New Delhi, and was responsible for designing and establishing the patient service labs, recruitment of medical

technologists, procurement of equipment and materials, developing Standard Operating Procedures (SOPs), QC guideline

as per Good Laboratory Practices (GLP), and creating complete documentation systems. The service laboratories

certification from European International Standard Organization (ISO)

In 1992, worked as Supervisor of Immunodiagnostics Services division at the National Health Laboratories, Inc.

(Presently called LabCorps) at Houston. Supervised 9 medical lab technologists conducting 2000 clinical tests daily.

Managed laboratory operations and certified QC and reported clinical reports to physicians.

Ethnic Disease Research: From 1987-1991, organized and directed a collaborative epidemiological study between Escorts

Heart Institute, New Delhi, India and Univ. of Texas Med. Branch, Galveston (UTMB) on the incidence of coronary artery

disease (CAD) among Asian-Indians. Developed clinical protocol for a comprehensive cardiac check-up (CCC) and

generated an omnibus data base on the ST-segment analysis during exercise-EKG, physical exam, lipid, profile, family

history, dietary inputs, and the incidence of CAD. Comparisons were made between the CAD patterns between Asian-Indians

and their European Caucasian counterparts. The screening program revealed higher incidence of CAD among Asian-Indians

compared to their White European counterparts.

From 1992-1995, at Texas Southern University (1992-1995) conducted NIH-RCMI (Research Centers in Minority

Institutions) funded research projects on Hypertension in African-American population. The disproportionately higher

incidence of the disease was investigated at molecular levels in animal models. Received federal grants from NIH- MBRS

(Minority Biomedical Research Support), and trained students and scientists belonging to the minority community. I have

supervised research presentations by African-American students at the national scientific meetings.

Medical Diagnostics Business Management: Founded, Directed & Managed as CEO for 7 years a Medical Product

business (Herichson Biotech, Inc.) in In Vitro Diagnostic (IVD) biotechnology in the United States. The products included

Coagulation products, Clinical Biochemistry reagents & ELISA products for the diagnosis of endocrine disorders,

cardiovascular disease, cancer and infectious diseases. Worked independently as well as in alliance with other corporate

bodies, managed all aspects of business operations including compliance with US-FDA regulations, & product registration

with Govt. of India. Established a bio-manufacturing facility as per cGMP guidelines to produce In Vitro Diagnostic (IVDs)

devices in Houston. Created product marketing & sales infrastructure in India.

5

Clinical Research Services: Organized and created working infrastructure to conduct clinical trials on new therapeutic

entities (NTEs).Clients included Aronex Pharmaceuticals, Inc. USA and Pharm-Olam International, a Houston-based CRO,

for anti-fungal drug trials on AIDS patients. Identified clinical trial Sites with suitable patient population, recruited

qualified physician investigators, and organized logistics for Government regulatory compliance. Fully aware and

experienced with Institutional Review Board (IRB) for patient safety issues and Informed Consent in Clinical Trials.

Government & Foundation Panels: I serve on the Expert Panels of the National Institutes of Health (Cardiovascular

Sciences) and National Science Foundation (NSF), both Federal government agency, for the scientific review and

recommendations on the allocation of resources for research investigators and institutions. Previously, I also served on

special National Panel for Site Visit to Charles Drew Medical School, Los Angeles, CA for review of a $ 5.0 Million grant for

institutional development. I have also served on the Expert Panel of the American Heart Association.

Scientific Editorial Panels: Continue to serve on editorial boards of national and international medical and biomedical

journals to review scientific research manuscripts. Have also written Research Review articles, monographs, research

reports and commentaries.

Journalistic Endeavors: As Extra-Curricular hobby I write Opinion Editorials (Op-Ed) Columns for newspapers, magazines

on subjects of current social and political contexts. (Listed in Resume under Extra-Curricular Activities)

MEDICAL RESEARCH GRANTS:

1. “Vascular signal transduction in hypertension” Principal Investigator: Chandra K. Mittal, Ph.D, National Institutes of Health, $ 287,424 (9/94 – 8/98)

2. “Actions of Atrial Natriuretic Peptide (ANP) on vascular smooth muscle in hypertension” Principal Investigator: Chandra K. Mittal, Ph.D., Am. Heart Assoc., $ 30,000 (7/85 – 6/87)

3. “Regulation of myocardial cyclic GMP synthesis” Principal Investigator: Chandra K. Mittal, Ph.D., Am. Heart Assoc., $ 30,000 (7/81 – 6/83)

4. “Cholinergic modulation of myocardial cyclic GMP” Principal Investigator: Chandra K. Mittal, Ph.D., Univ. IL Res. Board, $ 10,000 (7/81 – 8/82)

5. “Cyclic nucleotide metabolism during senescence”

Principal Investigator: Chandra K. Mittal, Ph.D., NIH 80417 (6/80 – 8/81)

6. “Pharmacological modulation of cyclic GMP metabolism” Principal Investigator: Chandra K. Mittal, Ph.D., Am. Heart Assoc. $ $ 16,000 (7/78 – 12/79)

7. “Mechanism of physiological modulation of cyclic GMP synthesis” Principal Investigator: Chandra K. Mittal, Ph.D., Pharmaceutical Manufacturers Association Foundation. $ 16,000 (1/78 – 12/79)

6

MEDICAL RESEARCH SUPERVISION

John Heimanz, B.S. Medical Research Fellow (1975) Robert Aldred, B.S. Research Assistant (1975-78) Kikuo Ichihara, M.D. Research Associate (1977-78) Mahmoud El-Zayat, Ph.D UNESCO Fellow (1977-78) William P. Arnold, M.D. Clinical Fellow (1977-78) J.Mark Braughler, Ph.D Postdoctoral Fellow (1977-78) Akihiko Wada, M.D. Research Associate (1978-80) Julia Ruffin, B.S. Research Assistant (1978-80) Rose Duffield, M.S. Research Technologist (1980-87) Mohammad Gabr, B.S. Research Assistant (1981-83) John Groch, B.S. Medical Research Fellow (1983) Sharon Murnan, M.S. Research Technologist (1983-84) Jeff Hallet, B.S. Medical Research Fellow (1984) Valerie Grondin, M.S. Research Specialist (1985-86) Anuradha Sureka, M.D. Research Fellow (1985-86) Mark Richman, B.S. Research Scientist (1988-91) Shelley Verma, M.A. Research Assistant (1987-90) Arun Raizada, M.S. Research Biochemist (1987-91) S. K. Jha, M.S. Research Assistant (1988-91) Rita Singhal, Ph.D. Research Fellow (1994-95) Andrew O Anugwom, B.Pham. Research Assistant (1994-95) Igeoma ‘Robin’ Okpara Research Assistant (1994-95) James George, B.S. Research Assistant (1995)

STUDENT RESEARCH PROJECTS:

1. HCC-UST Collaborative STEM Project: Characterization of Mosquito population. 2. HCC-UST Collaborative STEM Project: Physical Properties of Various Lipoprotein Particles. 3. Astra-STEM Research Project: Immuno-Chemical Diagnosis of Cancer 4. Astra-STEM Research Project: Detection of Cancer Bio-Markers

7

INVITED SCIENTIFIC LECTURES

1. All-India Institute of Medical Sciences, New Delhi, India (1976) 2. Smith Kline & French Laboratories. USA (1979) 3. Medical College of Virginia, Richmond, VA (1979) 4. Indiana University School of Medicine, Evansville, IN (1979) 5. University of Illinois College of Medicine, Peoria, IL (1979) 6. All-India Institute of Medical Sciences, New Delhi, India (1982) 7. Patel Chest Institute, University of Delhi, Delhi, India (1982) 8. Ciba-Geigy Pharmaceuticals, Summit, N.J (1882) 9. R.W.Johnson Institute, N.J. Raritan, N.J. (1983) 10. Texas Tech University School of Medicine, Lubbock, Texas (1984) 11. Hoffmann La Roche Pharmaceuticals, Nutley, N.J. (1984) 12. Central Drug Research Institute, Lucknow, India (1985) 13. Indian Institute of Technology, New Delhi, India (1985) 14. Jawaharlal Nehru University, New Delhi, India (1986) 15. University of Illinois College of Medicine, Chicago, IL. (1986) 16. Indian Toxicology Research Center, Lucknow, India (1986) 17. Mahatma Gandhi Medical College, Indore, India (1987) 18. Central Drug Research Institute, Lucknow, India (1988) 19. Defense Institute of Physiology & Allied Sciences, Delhi, India (1989) 20. University of Houston College of Pharmacy, Houston, TX (1990) 21. Baylor College of Medicine, Houston, TX (1990) 22. Henry Ford Heart Research Institute, Detroit, MI (1991) 23. Texas Southern University, Houston, TX (1992) 24. University of Puerto Rico, San Juan, Puerto Rico (1995) 25. Ministry of Science & Technology, Govt. of India, Delhi (1998) 26. Hamdard University, Delhi, India (1998) 27. All-India Institute of Medical Sciences, New Delhi, India (1999) 28. Torrent Pharmaceuticals, Ahmedabad, India (1999) 29. Dr. Reddy Research Foundation, Hyderabad, India (1999) 30. Indian Oil Corporation Research Center, Faridabad, India (1999) 31. India Medical Association, Roorkee Chapter, Roorkee, India (2000) 32. University College of Medical Sciences, Delhi, India (1999) 33. Malhotra Heart Institute, New Delhi, India (2000) 34. Department of Biochemistry, University of Lucknow, Lucknow, India (2001) 35. Dept. of Biotechnology, AIIMS, New Delhi, India (2001) 36. King George Medical University, Lucknow, India (2003) 37. Biophex 2004, San Francisco, CA (2004) 38. International Conference on Drug Development, AIIMS, Feb 2007 39. Amity Institute of Biotechnology, Amity University, NOIDA, India, May, 2007 40. Dr. & Mrs. G. P. Talwar Oration Award, Association of Clinical Biochemists of India (2007) 41. Apeejay Institute of Management, New Delhi, India (2008) 42. Sharda University, Greater Noida, India (2009) 43. Apeejay Institute of Management, New Delhi, Ind a(2009) 44. Sharda University Research Development & Technology Center, Greater Noida, India (2010) 45. Amity Institute of Microbial Technology, Amity University, NOIDA, India, August, 2012

8

SCIENTIFIC PUBLICATIONS

Peer-Reviewed Articles:

1. Mittal, CK: Studies on adenylate cyclase and cyclic AMP phosphodiesterase in chick brain. Ph.D. Thesis, All-India Institute of Medical Sciences, New Delhi, India (1974)

2. Kimura,H., Mittal, CK and Murad, F: Activation of guanylate cyclase from rat liver and other tissues

by sodium azide. J. Biol. Chem. 250, 8016-8022 (1975)

3. Mittal, CK., Kimura, H and Murad, F: Requirement of a macromolecular factor for sodium azide activation of guanylate cyclase. J. Cyclic Nucl.Res. 1, 261-269 (1975)

4. Kimura, H., Mittal, CK and Murad, F: Increases in cyclic GMP levels in brain and liver with sodium azide - an activator of guanylate cyclase. Nature 257, 700-702 (1975)

5. Kimura, H., Mittal, CK and Murad, F: Appearance of magnesium guanylate cyclase activity after sodium azide activation. J. Biol. Chem. 251, 7769-7773 (1976)

6. Mittal, CK and Murad, F: Formation of adenosine 3’,5’-monophosphate by preparations of guanylate cyclase from rat liver and other tissues. J. Biol. Chem. 252, 3136-3140 (1977)

7. Mittal, CK, Kimura, H, and Murad, F: Purification and properties of a protein factor required for sodium azide activation of guanylate cyclase. J. Biol. Chem. 252, 4384-4390 (1977)

8. Murad, F., Kimura, H., Mittal, CK and Arnold, WP: Guanylate cyclase - Properties and regulation.

Endocrinology V Int. Cong. Vol I, 507-511 (1977)

9. Katsuki, S., Arnold, WP Mittal, CK and Murad, F: Stimulation of guanylate cyclase by sodium nitroprusside, nitroglycerine and nitric oxide in various tissues and comparison to effects of sodium azidse and hydroxylamine. J. Cyclic Nucl. Res. 3, 23-35 (1977)

10. Mittal, CK and Murad, F: Activation of guanylate cyclase by superoxide dismutase and hydroxyl radical - a physiological regulator of guanosine 3’,5’-monophosphate formation. Proc. Nat. Acad. Sci,US 74, 4360- 4364 (1977)

11. Mittal, CK and Murad, F: Properties and oxidative regulation of guanylate cyclase. J. Cyclic Nucl. Res.

3, 381-391 (1977)

12. Arnold, WP., Mittal, CK., Katsuki, S and Murad, F: Nitric oxide activates guanylate cyclase and increases cyclic GMP levels in various tissues. Proc. Nat. Acad. Sci, US 74, 3203-3207 (1977)

13. Katsuki, S., Arnold, WP., Mittal, CK and Murad, F: Stimulation of formation and accumulationof cyclic GMP by smooth muscle relaxants. Proc. 2nd Cyclic Nucleotide Conference, Japan. Pp 45-51 (1977)

14. Mittal, CK. Arnold, WP and Murad, F: Characterization of protein inhibitors of guanylate cyclase activation from rat heart heart and bovine lung. J. Biol. Chem. 253, 1266-1271 (1978)

9

15. Mittal, CK and Murad, F: Formation of cyclic AMP by guanylate cyclase after activation with azide, nitro- and nitroso-compounds. Adv. Cyclic Nucle. Res. 9, 742, (1978)

16. Muard, F., Mittal, CK., Arnold, WP., Katsuki, S., and Kimura, H: Guanylate Cyclase: Activation by azide, nitro compound, nitric oxide and hydroxyl radical and inhibition by hemoglobin and myoglobin. Adv. Cyclic Nucl. Res. 9, 145-158 (1978)

17. Murad, F., Mittal, CK., Arnold, WP., Ichihara, K., and Braughler, JM: Properties and regulation of guanylate cyclase: Activation by azide, nitro-compounds and hydroxyl radical and effect of heme containing proteins. Mol. Biol & Pharmacol. (Cyclic Nucleotides) pp. 33-42 (1978), Elsevier Press.

18. Mittal, CK., Braughler, JM., Ichihara, K and Murad, F: Synthesis of adenosine 3’,5’-monophosphate

by guanylate cyclase: A new pathway for its synthesis. Biochim. Biophys. Acta. 585, 333-342 (1979)

19. Braughler, JM., Mittal, CK and Murad, F: Purification of soluble guanylate cyclase from rat liver.

Proc. Nat. Acad. Sci, US 76, 219-222 (1979)

20. Ichihara, K., El-Zayat., Mittal, CK and Murad, F: Fatty acid activation of guanylate cyclase from fibroblast and rat liver. Arch. Biochem. Biophys. 197, 44-51 (1979)

21. Murad, F., Arnold, WP., Mittal, CK and Braughler, JM: Properties and regulation and role of guanylate cyclase and cyclic GMP. Adv. Cyclic Nucle. Res. 11, 175-204 (1979)

22. Murad, F., Mittal, CK., Arnold, WP and Braughler, JM: Effect of nitro-compounds, smooth muscle relaxats and other materials on cyclic GMP metabolism. Adv. Pharmacol. Therp. 3, 123-132 (1978)

23. Braughler, JM., Mittal, CK and Murad, F: Effect of thiols, sugars and proteins on nitric oxide on activation of guanylate cyclase. J. Biol. Chem. 254, 12450-12454 (1979)

24. Murad, F., Lewicki, JA., Brandwein, HJ., Mittal, CK and Waldman, SA: Guanylate cyclase: Guanylate cyclase: Purification, properties, free-radical activation, radiolabeling and preparation of hybridoma monoclonal antibodies. Adv. Cyclic Nucl. Res. 14, 229-240 (1981)

25. Mittal, CK and Murad, F: Guanylate cyclase: Regulation of Cyclic GMP metabolism. Handbook Exptl. Pharmacol. 58/I, 225-260 (1982)

26. Lewicki, JA., Brandwein, HJ., Mittal, CK and Murad, F: Properties of purified soluble guanylate cyclase by nitric oxide and sodium nitroprusside. J. Cyclic Nucle. Res. 8, 17-25 (1982)

27. Mittal, CK: Phospholipase A2 modulation of cyclic GMP metabolism: Activation of guanylate cyclase.

Int. J. Biochem. Biophys. 21, 44-46, (1984)

28. Mittal, CK: Cholinergic-muscarinic receptors in myocardium: Properties of (3-H) quinuclidinyl benzilate binding. Int. J. Exptl. Biol. 23, 300-305 (1985)

29. Mittal, CK: Phospholipase A2-modulation of cyclic GMP metabolism: Characteristics of guanylate cyclase activation. Life Sci. 37, 2143-2149 (1985)

10

30. Mittal, CK: Molecular interaction of vasodilators: Modulation of cyclic GMP by nitro-drugs and atrial natriuretic factor (ANF). Ind. J. Heart Res. 2, 21 (1985)

31. Mittal, CK: Atriopeptin II and nitrovasodilator-mediated shifts in cyclic GMP in rat thoracic aorta: Evidence for involvement of distinct guanylate cyclase pools. Eup. J. Pharmacol. 115, 127-128 (1985)

32. Mittal, CK: Science in India. Nature, 311, 8 (1984)

33. Mittal, CK: Determination of guanylate cyclase and adenylate cyclase activities in cells of immune system. Methods in Enzymol. 132, 422-428 (1986)

34. Mittal, CK: Measurement of cyclic AMP and cyclic GMP levels in polymorphonuclear leukocytes, macrophages and lymphocytes. Methods in Enzymol. 132, 428-434 (1986)

35. Mittal, CK, Actions of atrial natriuretic peptides on cyclic GMP system in vascular smooth muscle. Int. J. Exptl. Biol. 25, 24-28 (1987)

36. Mittal, CK: Interaction of atrial natriuretic peptides in hypertension. Ind. J. Physiol. Pharmacol. 31, 5-6 (1987)

37. Mittal, CK: Management of Science in India. Times of India (Feature), May (1988) 38. Mittal, CK: Membrane receptors for catecholamines and atrial peptides in hypertension. Proc Int. Symp.

Biomemb. Dis. (1989), Raven Press, N.Y 39. Mittal, CK and Jadhav, AL: Renal atrial natriuretic peptide (ANP receptors during sodium-loading. Clin.

Pharmacol. Therap. 53, 234 (1993)

40. Mittal, CK: Nitric oxide synthase: Involvement of oxygen-radicals in conversion of L-arginine to nitric oxide. Biochem. Biophys. Res. Commun. 193, 126-132 (1993)

41. Mittal, CK: Decrease atrial peptide receptors in adrenal gland in spontaneously hypertensive rats (SHR) Am. J. Hyperten. 6, 431-433 (1993)

42. Dayal. HH., Ui-hwei Li., Dayal, V., Mittal, CK and Snodgrass, W. On utility of medication data in community- based symptoms prevalence studies. Arch. Environ. Health 49, 93-97 (1993)

43. Mittal, CK: Characterization of L-arginine effect on cyclic GMP system in neuroblastoma cells. Proc. Texas Acad. Sci. p. 35, (1994)

44. Mittal, CK and Jadhav, AL: Calcium-dependent inhibition of constitutive nitric oxide synthase. Biochem. Biophys. Res. Commun. 203, 8-15 (1994)

45. Mittal, CK and Jadhav, AL: Calcium-dependent regulation of brain constitutive NO synthase: Mechanism of

NO generation and its dual control by calcium ion. Proc. Int. Conf. Biochem. Mol. Biol. Nitric Oxide, p. 71 (1994)

46. Mittal, CK: Oxygen-radicals/nitric oxide mediate calcium-dependent actions of hormones on cyclic GMP system: A novel concept in signal transduction. Mol. Cell. Biochem. 149, 257-262 (1995)

11

47. Mittal, CK., Houston, DE., Harrell, WB and Mehta, CS: Interaction of heavy metal toxicants with brain nitric oxide synthase. Mol. Cell. Biochem. 149, 263-265 (1995)

48. Mittal, CK and Mehta, CS: Regulation of nitric oxide synthase: Role of oxygen-radicals and cations in nitric oxide formation. Adv. in Pharmacol. 34, 235-250 (1995)

49. Mittal, CK: NO synthase-independent conversion of L-arginine to L-citrulline: A potential source of error in NOS activity determination. FASEB J. 9, 681 (1995)

50. Anugwom, AO., Singhal, R and Mittal, CK: Reversal of NO-activated guanylate cyclase by hemoglobin and methylene blue. FASEB. J 9, 676 (1995)

51. Mittal, CK: Nitric oxide and oxygen-radicals in signal transduction mechanisms- Implication in cardiovascular disorders. Proc. Current Trends in Cardiovas. Res., San Juan, Puerto Rico (1995)

52. Mittal, CK., Mittal, R and Galiotos, J.A: Nitric Oxide: Regulation and Clinical Relevance. Trends in Clinical Biochem, pp 577-580 (2003), Assoc. Clin. Biochem. India

53. Mittal, CK: Oxygen-Radicals as Bio-Regulators: A Novel Concept in Physiology, Proc. Am. Assoc. Physicians of

Indian Origin, December 22-23, (2003) 54. Mittal, CK: Anatomy of Discovery of Nitric Oxide-Cyclic GMP Signaling System: A Novel Platform for

New Drugs & Diagnostics. Indian J. Clin. Biochem, 22, 19-20 (2007)

55. Richa Chandra, Birgit Mellis, Kyana Garza, Samee A. Hameed a, James M. Jurica, Ana V. Hernandez,

Mia N. Nguyen, Mittal, CK: Remnant lipoprotein size distribution profiling via dynamic light scattering analysis. Clinica Chimica Acta. Vol. 462, 6-14 (2016)

56. Mittal, CK: Nitric Oxide-Cyclic GMP Signaling: Discovery, Regulation, Therapeutic and Nutritional Significance.

J. Mol. Biol. & Therap. (Invited Review in Preparation), 2019

12

Abstracts:

1 Mittal, CK and Sharma, SK: Adenylate cyclase in developing chick brain. Symp. Mol. Mech. Drug Act. CDRI, India

(1970)

2. Mittal, CK and Sharma, SK: Ontogenetic development of adenylate cyclase. Proc. 40the Soc. Biol. Chem. India,

1971

3. Mittal, CK and Sharma, SK: Adenylate cyclase and cyclic AMP-phosphodiesterase in development. Proc. Int. Symp. Brain & Behav. India (1972)

4. Mittal, CK., Joshi, A and Sharma, SK: Adenylate cyclase in nerve cell bodies and glial cells from rat cerebral cortex. Proc. 41st Soc. Biol. Chem. India (1972)

5. Kimura, H., Mittal, CK and Murad, F: Activation of guanylate cyclase by sodium azide. Clin. Res. 23, 324 (1975)

6. Kimura, H., Mittal, CK and Murad, F: Sodium azide activation of guanylate cyclase. Proc. VI Int. Cong. Pharmacol. P. 392 (1975)

7. Mittal, CK., Kimura, H and Murad, F: Activation of guanylate cyclase by sodium azide. Gordon Conf. “Cyclic Nucleotides” (1975)

8. Kimura, H., Mittal, CK and Murad, F: Magnesium-dependent guanylate cyclase after sodium azide activation. Fed. Proc. 35, 434 (1976)

9. Mittal, CK and Murad, F: Formation of cyclic AMP by guanylate cyclase preparation after activation with sodium azide. Clin. Res. 25, 49 (1977)

10. Mittal, CK., Kimura, H and Murad, F: Properties of a protein factor required for sodium azide activation of guanylate cyclase. Fed. Proc. 36, 737 (1977)

11. Katsuki, S., Arnold, WP., Mittal, CK and Murad, F: Stimulation of guanylate cyclase in various tissues by nitroprusside, nitroglycerine, hydroxylamine and sodium azide. Clin. Res. 25, 58 (1977)

12. Braughler, JM., Mittal, CK and Murad, F: Purification and properties of guanylate cyclase. Gordon Conf. “Cyclic Nucleotides” (1978)

13. Arnold, WP., Katsuki, S., Mittal, CK and Murad, F: Stimulation of guanylate cyclase by nitric oxide. Adv. Cyclic Nucle. Res. 9, 743 (1978)

14. Ichihara, K., El-Zayat, M., Mittal, CK and Murad, F: Activation of guanylate cyclase from fibroblast and liver by fatty acids. Fed. Proc. 37, 390 (1978)

15. Arnold, WP., Braughler, JM., Mittal, CK and Murad, F: Activation of guanylate cyclase by thiols. Fed, Proc. 37, 390 (1978)

16. Mittal, CK and Murad, F: Effect of phospholipase A2 and lipoxigenase on guanylate cyclase. Fed. 37, 1689 (1978)

13

17. Mittal, CK and Murad, F: Cyclic AMP formation by guanylate cyclase. Clin. Res. 26, 531 (1978)

18. Braughler, JM., Mittal, CK and Murad, F: Purification of soluble guanylate cyclase from rat liver to apparent homogeneity. Clin. Res. 27, 788 (1979)

19. Mittal, CK., Braughler, JM and Murad, F: Modulation of purified guanylate cyclase by proteins. Fed. Proc. 38, 318 (1979)

20. Wada,A., Mittal, CK and Murad, F: Cyclic GMP levels and B-glucuronidase from human polymorphonuclear leukocytes. Clin. Res. 28, 498 (1980)

21. Mittal, CK: Guanylate cylcase: an alternate pathway for cyclic AMP formation. Proc. Asian & Oceanian Biochem (1981)

22. Mittal, CK: Clonidine and prazosin receptors in neurogenic hypertension. Fed. Proc. 42, 647 (1983)

23. Mittal, CK., Duffield, R and Luqman, GA: Nitrendipine, prazosin, clonidine and QNB binding in brain memebranes from normotensive and hypertensive rats. Pharmacologist 25, 240 (1983)

24. Mittal, CK: Age-dependent alterations in cholinergic-muscarinic receptors and cyclic GMP metabolism. Fed. Proc. 43, 624 (1984)

25. Ho, A., Mittal, CK and Hjelle, JT: Subcellular distribution of calmodulin and guanylate cyclase in kidney proximal tubules. Fed. Proc. 43, 766 (1984)

26. Mittal, CK., Groch, JS and Kalyan-Raman, U: Guanylate cyclase and cholinergic receptors sites in human brain tumors. Clin. Res. 32, 419 (1984)

27. Mittal, CK., Hallet, JF and Kalyan-Raman, K: Ca2+ modulation of RBC cyclic GMP in muscular dystrophy patients. Clin. Res. 33, (1985)

28. Mittal, CK and Duffield, R: Interaction of atriopeptine with thoracic aorta and renal membranes. Proc. Int. Heart Soc (1986)

29. Mittal, CK: Atriopeptin and phospholipase A2 dependent modulation of cyclic GMP-guanylate cyclase system. Fed.Proc. 46, 192 (1986)

30. Mittal, CK: Atrial natriuretic protein (ANP) receptor in vascular smooth muscle: Characterisitcs and properties> Pharmacologist 28, 93 (1986)

31. Mittal, CK: Effect of cations on atrial natriuretic protein (ANP) receptors in vascular smooth muscle . Fed. Proc. 47, (1987)

32. Mittal, CK: Atrial natriuretic peptide (ANP) receptors in genetic hypertension. FASEB J. 6, (1992)

33. Mittal, CK: Formation of nitric oxide by NO synthase requires oxygen-radicals. Pharmacologist 35, 162 (1993)

34. Mittal, CK and Jadhav, AL: Effect of cations on nitric oxide synthase. FASEB J. 8, 362 (1994)

14

35. Mittal, CK: Oxygen-radicals and nitric oxide mediate hormonal regulation of cyclic GMP system. Proc. Int. Symp. Sec. Messengers, Trinidad, June, 1994

36. Mittal, CK and Houston, D: Differential modulatory effects of heavy-metal toxicants on constitutive NO synthase activity. The Toxicol. 15, 10 (1995)

37. Mittal, CK and Mehta, CS: Nitric oxide synthase - A new target for envirnmental toxicants. Proc. Am. Chem. Soc. (1995)

38. Mehta, CS and Mittal, CK: Role of cyclic GMP in the neurotoxicity of trimethyltin in rats. Int. Cong. Toxicol. P.12 (1995)

39. Mittal, CK: Phospholipid-phospholipase A2 dependent activation of particulate guanylate cyclase. 9th Int. Conf. 2nd. Messenger & Phosphoproteins (1995)

40. Mittal, CK: Discovery of Nitric oxide signaling system: A novel concept in signal transduction. Ind. J. Pharmacol. Dec 1998

41. Mittal, CK: Nitric Oxide: Discovery & Importance in Cardiovascular Diseases. Proc. 9th Asian Pac. Congress Clin. Biochem (2002)

42. Mittal, CK and Galiotos, J.A: Biotechnology Education at Houston Community College. Am. Chem. Soc. (in press, 2003)

43. Mittal, CK, Theresa L. Spain and Galiotos, J.K: “Development of Enzyme-Linked Immunosorbent Assay (ELISA) kit – An Important biotechnological tool for medical diagnostics and therapeutics. Am. Chem. Soc. (2003)

44. Mittal, CK and Galiotos, J.K: Biotechnology Education at Community Colleges-An Emerging Challenge. Am. Soc. Biochem & Mol. Biol. (2003)

45. Mittal, CK: Community Colleges as Business Incubators – A Novel Concept for Small Businesses in Biotechnology. Biophex 2004 Conference, San Francisco, CA, September 28-30, 2004.

46. Mittal, CK, Galiotos, JK and Hernandez, KJ: Structuring a Workforce Training Program for Global Biotechnology Industry, FASEB J. 2005

47. Mittal, CK, Sen, P, Spain, T, Galiotos, G, and Hernandez, K: A Model Curriculum for Training in Molecular Diagnostics. Proc. XIX International Clinical Chemistry (2005) & Am. Assoc. Clin. Chem (2005)

15

EXTRA-CURRICULAR ACTIVITIES

Newspaper Articles and Op-Ed Columns

1. Science in India. Nature, vol. 311, p8 (1984)

2. Management of Science in India. Times of India (May, 1988)

3. Is Indian Prime Minister Narendra Modi, Ronald Reagan of India? Voice of Asia, Vol. 27, No 28 (2014)

4. Is Indian Prime Minister Narendra Modi, Ronald Reagan of India? India Tribune, Chicago, August 15, 2014

5. Narendra Modi – A Transformative Leader for 21st Century India. India Tribune, Chicago, August 22, (2014)

6. Narendra Modi: Transformational Leader for 21st Century. India West, San Leandro, CA, Oct 31, (2014)

7. Indian Cultural Values versus American Democratic System. Voice of Asia, Houston, Vol. 27, No. 34 (2014)

8. Hinduism – A World Force for Peace, Tranquility and Happiness. Voice of Asia, Vol. 27, No. 42, (2014)

9. Dawn of a New Era in US-India Bilateral Relations. Voice of Asia, Houston, Vol. 27, No. 48, (2014)

10. India Needs District-Level Governing Autonomy for Prosperity and Stability - An Open Letter to Prime Minister Narendra Modi. Voice of Asia, Houston, Vol. 27, No. 51 (2014)

11. India Needs District-Level Governing Autonomy for Prosperity and Stability - An Open Letter to Prime Minister

Narendra Modi.. India New England, Waltham, MA (2014) 12. India Needs District-Level Governing Autonomy for Prosperity and Stability - An Open Letter to Prime Minister

Narendra Modi. The South Asia Times, New York, p. 12, Dec 27th (2014) 13. India Needs District-Level Governing Autonomy for Prosperity and Stability - An Open Letter to Prime Minister

Narendra Modi. NRI-Press, California (2014)

14. India’s Simultaneous Rendezvous with United States and Russia: New Economic Pragmatism in the changing World. Voice of Asia, Houston, Vol. 28, No 1 (2015)

15. India’s Simultaneous Rendezvous with United States and Russia: New Economic Pragmatism in the changing World. The South Asia Times, New York, Jan 17th (2015)

16. A Historic Day, a Historic Event: Obama Visit to India. www.indiacurrents.com/articles/2015/01/27 17. American Philanthropy - A symbol of American Exceptionalism. VOICE OF ASIA Vol. 28, No. 18 p10, 2015

18. American Philanthropy - A symbol of American Exceptionalism. The South Asia Times, NY (April 26, 2015)

19. Is Political Correctness Undermining American Civilization? Voice of Asia Vol. 28, No. 20, p2, 2015 20. Is Political Correctness Undermining American Civilization? India Tribune, Chicago, May 22, 2015

21. Economic Globalization versus National Sovereignty- New Challenges and Solutions in the Transforming World. Voice of Asia Vol. 28, No. 22, p2, May 29, 2015

16

22. Modi’s New India: A View from the Main Street. Voice of Asia, Vol. 28, No. 30, p2, 2015 23. Greece Debt Crisis – A Greek Tragedy without Catharsis. VOICE OF ASIA. Vol. 28, No. 31, p8, (2015) 24. Modern India Needs Presidential Form of Government: A Model for National Stability, Prosperity & Progress. VOICE

OF ASIA Vol. 28, No. 28, p2, 2015

25. Iranian Nuclear Agreement: An Exercise in Global Economic Pragmatism. Voice of Asia, Vol. 28, No. 33, p2, (2015), 26. Multi-Culturalism in America: An Asset or Liability for Society. Voice of Asia, Vol. 28, No. 36, p2, 2015, 27. Syrian Refugee Crisis is Failure of United Nations. Voice of Asia, Vol. 28, No. 39, p2, 2015 28. Mahatma Gandhi: An Apostle of Non-Violence. Voice of Asia, Vol. 28, No. 40, p10, 2015 29. NARENDRA MODI: An Opportune Moment to Settle Indo-Pakistan Dispute. Voice of Asia, Vol. 28, No. 40, 2015 30. Opportune Time to Settle Indo-Pak Dispute. India West Oct 9, 2015 31. INCLUSIVE CAPITALISM: Panacea for Prosperity in Stagnant Economy. Voice of Asia, Vol. 28, No. 42, 2015 32. THE BENGHAZI BUNGLE: A High-Powered Political Deception. Voice of Asia, Vol. 28, No. 44, p2, 2015, 33. AMERICAN CONSTITUTION: The Holy Book for all American. Voice of Asia, Vol. 29, No. 1, p2, 2016 34. Over-Speculative US Capitalism: A Source of Public Discontent and Political Divide. Voice of Asia, Vol. 29, No. 12, p2, 2016 35. Demonizing American Muslims is Not American. INDIA-WEST, April 29, 2016 36. Demonizing American Muslims is Not American: An Indo-American Perspective. Voice of Asia, Vol. 29, No. 18, p2, 2016 37. Can Populism Alone Propel Donald Trump into US Presidency? Voice of Asia, Vol. 29, No. 19, p2, 2016 38. Orlando Tragedy Sadly Becoming Political Opportunism. Voice of Asia. Vol. 29, No. 26, p7, 2016 39. BREXIT – A Warning for all Industrialized Nations. Voice of Asia, Vol. 29, No. 27, p2, 2016 40. An Idea Called America - A Tribute to Independence Day. Voice of Asia, Vol. 29, No. 28, p7, 2016 41. India’s Permanent Ruling Class: A Curse for Indian Democracy after 70 Years of Independence. Voice of Asia Vol. 29, No. 34, p2, 2016 42. India’s Permanent Ruling Class: A Curse for Indian Democracy after 70 Years of Independence. India Tribune, Vol. 40, No. 18, p6, 2016 43. Term-Limits in Elected Office is Key to Success and Stability of Democracy. Voice of Asia, Vol. 29, No. 38, p2, 2016

17

44. US Needs to Regulate Immigration to Control its Destiny. Voice of Asia, Vol. 29, No. 40, p2, 2016 45. Presidential Choice between Donald Trump and Hillary Clinton: A Dilemma for Voters and American Democracy. Voice of Asia, Vol. 29, No. 41, p2, 2016 46. Changing American Nationalism in age of Globalization: A Challenge in 2016 Presidential Election. Voice of Asia, Vol. 29, No. 44, p2, 2016 47. Inclusion of Minorities is Essential for President Trump’s Success. Voice of Asia, Vol. 29, No. 46, p2, 2016 48. Inclusion of Minorities is Essential for President Trump’s Success. India Tribune, Vol 40, No. 24, 2016 49. Inclusion of Minorities Essential for Success of President-elect Trump. INDIA-WEST, p6, Dec 2, 2016 50. Ignorance and Bigotry is not Conservatism: A Word of Caution for American Conservative Activists. Voice of Asia, Vol. 29, No. 50, p2, 2016

51. Do You Really Need Added Sugar in Your diet. Healthline, Vol.2, No.4, p17 (2016)

52. What can President Donald Trump actually deliver? The Challenges for the 45th US President

Voice of Asia, Vol. 30, No.2, p2, 2017

53. The Challenges for President-elect Trump. INDIA-WEST, p6, Jan 20, 2017 54. What can President Trump Actually Deliver, INDIA JOURNAL Jan 13, 2017

55. Kansas City Shooting of Indians: Not Political Conspiracy but Act of a Deranged Xenophobe.

Voice of Asia, Vol. 30, No.9, p2, 2017 56. American Healthcare - a Privilege or a Right, An Unending Debate and Dilemma for American Political System.

Voice of Asia, Vol. 30, No. 12, p4, 2017 57. Kansas Shooting: Isolated Act of a Lunatic Xenophobe? INDIA-WEST, p8, April 7, 2017 58. The First 100-Days Presidential Review Mania: A Media Creation of No Consequence. Voice of Asia, Vol. 30, No. 18,

p4, 2017 59. 100-Days Media Mania About Presidential Performance. INDIA-WEST, p.8/16, May 5, 2017 60. Demonetization in India: An Economic Reform with Cultural Dilemma. Voice of Asia, Vol. 30, No. 29, p9, 2017 61. Demonetization: Economic Reform That Hurts, INDIA-WEST, p6, August 4, 2017 62. Has Donald Trump Settled in US Presidency? Voice of Asia, Vol. 30, No. 30, p11, 2017 63. Can Donald Trump be an Effective President after Charlottesville? Voice of Asia, Vol. 30, No. 33, p 2, 2017 64. Can Donald Trump be an Effective President after Charlottesville? INDIA TRIBUNE, Sept 8, 2017 65. SEXUAL MISCONDUCT TRANSCENDS ETHNICITY AND NATIONALITY, INDIA JOURNAL, NOV 16, 2017

18

66. Sexual Misconduct Transcends Ethnicity and Nationality. Voice of Asia, Vol. 30, No. 45, p 4, 2017 67. Sexual Misconduct Transcends Ethnicity. INDIA-WEST, p. A6, Nov 24, 2017

68. Is President Trump’s Afghanistan Policy Too Transactional to Succeed? Voice of Asia, Vol. 30, No. 48, p 2, 2017 69. Sexual Misconduct Transcends Ethnicity and Nationality. INDIA TRIBUNE, p.6, Dec 2017

70. Politicization of Sexual Harassment is Detrimental to American Democracy. Voice of Asia, Vol. 30, No. 49, p 2,

2017

71. Did Donald Trump Meet Expectations in First-Year of his Presidency? Voice of Asia, Vol. 31, No. 1, p 2, 2018 72. Did Trump Meet Expectation First Year? INDIA-WEST. January 19, 2018, p.A6

73. Did Donald Trump Meet Expectations in First-Year of his Presidency? INDIA TRIBUNE. January 26, 2018, p.6

74. US-Pakistan Bilateral Relationship: A Dilemmatic Challenge for America. VOICE OF ASIA. Vol. 31, No. 3, p 2, 2018 75. Florida’s Valentine’s Day School Shooting: An Avoidable American Tragedy. VOICE OF ASIA. Vol. 31, No. 8, p 2,

2018.

76. Donald Trump Presidency at Crossroad of Morality and Legality. VOICE OF ASIA. Vol. 31, No. 17, p 2, 2018.

77. Is Vladimir Putin the Winner of Trump-Putin Summit on his Terms? VOICE OF ASIA. Vol. 31, No. 29, p 2, 2018

78. Is Vladimir Putin the Winner of Trump-Putin Summit on his Terms? INDIA TRIBUNE. August 10, 2018 p.6

79. CBS’s Leslie Moonves – A Symbol of Continued Menace of Sexual Misconduct. VOICE OF ASIA. Vol. 32, No. 38,

p2, 2018

80. Professor Christine Blasey Ford: A Victim of Dual Assault by Judge Brett Cavanaugh and Political Process.

VOICE OF ASIA. Vol. 32, No. 40, p2, 2018 81. Moral Values versus Strategic Interests: America’s Challenge with Saudi Arabia. VOICE OF ASIA. Vol. 32, No.42,

p2, 2018 82. America Must Reject Politics of Hate and Demonization in Election 2018. VOICE OF ASIA. Vol.32, No. 43, p2. 2018 83. Professor Christine Blasey Ford: A Victim of Dual Assault by Judge Brett Cavanaugh and Political Process. INDIA

TRIBUNE. Nov 16, 2018, p.6 84. Freedom of the Press: A Critical Lynchpin of American Democracy. VOICE OF ASIA. Vol. 32, No. 46, p.2 2018

85. Moral Values versus Strategic Interests: America’s Challenge with Saudi Arabia. INDIA TRIBUNE. Dec 14, 2018,

p.8

19

86. Freedom of the Press: A Critical Lynchpin of American Democracy. INDIA TRIBUNE. Dec 28, 2018, p6

87. US Congress 2019 New Year Resolution: Supermajority Votes for all Legislations. VOICE OF ASIA. Vol. 33, No.

1, p2, 2019

88. US Congress 2019 New Year Resolution: Supermajority Votes for all Legislations. INDIA TRIBUNE, January 25, 2019, p.6

89. US Government Shutdown: A Symbol of Constitutional Subversion and Congressional Failure. VOICE OF ASIA.

Vol. 33, No. 4, p2, 2019 90. US Government Shutdown: A Symbol of Constitutional Subversion and Congressional Failure. INDIA TRIBUNE,

February 8, 2019, p6 91. Declaration of National Emergency on US-Mexican Border: An Ineffective Political Maneuver by Donald Trump to

Pacify Conservatives. VOICE OF ASIA. Vol. 33, No. 8, p2, 2019 92. Mueller’s Investigation Creates a Puzzle that Needs Intervention by US Congress: VOICE OF ASIA. Vol. 33, No. 13,

p2, 2019 93. “Love or Leave America” – New Divisive Slogan of Donald Trump for Election 2020. VOICE OF ASIA, Vol. 33, No.

30, p2, 2019 94. Could Robert Mueller Testimony be a Prelude to Donald Trump’s Impeachment? VOICE OF ASIA. Vol. 33, No. 32,

p2, 2019 95. Revocation of Article 370: A Time for Pakistan to Move beyond Indian Kashmir. VOICE OF ASIA. Vol. 33, No. 34,

p2, 2019 96. India and Pakistan Present Contrasting National Values at United Nations. VOICE OF ASIA. Vol. 33, No. 41, p2,

2019 97. Modi: Zeal to Make India Global Power. INDIA WEST. p-A6, September 27, 2019 98. Narendra Modi: A Leader with Zeal to Make India Global Power. INDIA TRIBUNE, p6, October 4, 2019 99. India and Pakistan Present Contrasting National Values at United Nations. INDIA WEST. P-A8, October 18, 2019 100. India and Pakistan Present Contrasting National Values at United Nations. INDIA TRIBUNE. P6, November 1,

2019 101. To Remove or Not to Remove President Donald Trump from Office: A Politico-Moral Dilemma for Republican

Senators. VOICE OF ASIA, Vol. 34, No.4. p2, 2020 102. To Remove or Not to Remove President Donald Trump from Office: A Politico-Moral Dilemma for Republican

Senators. INDIA TRIBUNE, Feb 7, 2020 103. Statin-Chloroquine Combination: potential preventive drugs for COVID-19 pandemic. VOICE OF ASIA, Vol. 34,

March 19. 2020.

20

104. Statin-Chloroquine Combination: potential preventive drugs for COVID-19 pandemic. INDIA TRIBUNE, April 3,

2020